| 证券代码：300872 | 证券简称：天阳科技 | 公告编号：2025-052 | | --- | --- | --- | | 债券代码：123184 | 债券简称：天阳转债 | | 1、业绩说明会召开时间：2025 年 5 月 19 日（星期一）15:00-17:00。 2、业绩说明会召开方式：网络互动方式。 3、业绩说明会召开地点：价值在线（www.ir-online.cn）。 4 、 会 议 问 题 征 集 ： 投 资 者 可 于 2025 年 5 月 19 日 前 访 问 网 址 https://eseb.cn/1o72UPUYZAk 或使用微信扫描下方小程序码进行会前提问，公司 将通过本次业绩说明会，在信息披露允许范围内就投资者普遍关注的问题进行回 答。 天阳宏业科技股份有限公司（以下简称"公司"）已于 2025 年 4 月 25 日在巨 潮资讯网上披露了《2024 年年度报告》及《2024 年年度报告摘要》。为便于广 大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2025 年 5 月 19 日（星期一）15:00-17:00 在"价值在线"（www.ir-online.cn ...

| 证券代码：300872 | 证券简称：天阳科技 | 公告编号：2025-051 | | --- | --- | --- | | 债券代码：123184 | 债券简称：天阳转债 | | 天阳宏业科技股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情形。 2、本次股东大会不涉及变更前次股东大会决议情况。 一、会议召开情况 1、召开时间： （1）现场会议召开时间：2025年5月15日（星期四）14:00。 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为2025年5月15日9:15—9:25，9:30—11:30和13:00—15:00；通过深圳证券交易 所互联网投票系统进行网络投票的具体时间为2025年5月15日9:15—15:00期间的 任意时间。 2、现场会议地点：北京市朝阳区望京SOHO塔二B座22层。 3、会议召集人：公司董事会。 4、会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式。 5、会议主持人：公司董事长欧阳建平先生。 6、 ...

Core Viewpoint - The financial technology sector is facing intense competition, prompting market participants to undergo structural adjustments in their business operations. Tianyang Technology (300872.SZ) reported a decline in revenue and profit for 2024, indicating challenges in maintaining growth amidst a competitive landscape [1][2]. Financial Performance - Tianyang Technology's total revenue for 2024 was 1.766 billion yuan, a year-on-year decrease of 8.76%, marking the second consecutive year of negative growth [2]. - The net profit attributable to shareholders was 77.5 million yuan, down 33.60% year-on-year, while the net profit excluding non-recurring items was 2.7165 million yuan, a significant drop of 95.75% [2]. - The net cash flow from operating activities was 123 million yuan, reflecting a 69.81% decline year-on-year [2]. - Basic earnings per share decreased by 27.59% to 0.21 yuan, and the weighted average return on equity (ROE) fell to 2.91%, down 1.78% year-on-year [2]. Revenue Composition - The decline in revenue was attributed to intense market competition and extended settlement cycles for large projects from major clients, leading to a decrease in recognized revenue [2][3]. - The company reported that revenue sources are shifting towards key banking business areas such as credit, credit cards, and data, with a focus on large banks [1][3]. Strategic Developments - Despite the decline in performance, Tianyang Technology continued to expand by establishing five new companies and acquiring one, while also dissolving three subsidiaries [4]. - The company is focusing on a "professionalization and productization" strategy, with over two-thirds of revenue coming from this approach in digital finance and intelligent credit applications [3]. Profitability Challenges - Three main factors negatively impacted profits: convertible bond interest payments, stock incentive payments, and goodwill impairment [5]. - The company issued convertible bonds totaling 975 million yuan, with interest expenses for 2024 amounting to 50.977 million yuan, which significantly affected profitability [5]. - The goodwill impairment related to the acquisition of a subsidiary, which reported a revenue increase but a profit decline, further strained financial results [7]. Future Outlook - Tianyang Technology's R&D investment for 2024 was 327 million yuan, representing an 18.53% investment rate, with a focus on developing intelligent financial applications [8]. - Analysts project revenue growth for 2025-2027, estimating revenues of 1.925 billion yuan, 2.130 billion yuan, and 2.387 billion yuan, with corresponding net profits of 101 million yuan, 135 million yuan, and 181 million yuan [8].

Investment Rating - The report maintains a positive investment rating for the computer industry, particularly highlighting the potential in AI-related companies [7]. Core Insights - The computer industry is experiencing revenue pressure, but a profit turning point has been observed. The overall revenue growth rate for the computer sector is expected to decline in 2024, with a notable recovery in profits in the first quarter of 2025 [5][11]. - In 2024, the computer sector is projected to achieve total operating revenue of CNY 12,614.80 billion, a year-on-year decrease of 1.65%. The net profit attributable to shareholders is expected to be CNY 294.24 billion, down 9.39% year-on-year [11][14]. - The first quarter of 2025 shows signs of recovery, with operating revenue reaching CNY 2,862.17 billion, an increase of 2.56% year-on-year, and net profit attributable to shareholders rising by 6.05% to CNY 58.79 billion [11][12]. Summary by Sections Market Review - During the week of April 28 to May 2, the CSI 300 index fell by 0.43%, while the computer sector (CITIC) rose by 2.66%. The top five gainers included companies like Chuangyi Information and Lingzhi Software, while the biggest losers included Dongfangtong and Quanzhi Technology [3][59]. Industry News - The report highlights significant developments in the AI sector, with companies like Yaxin Security and Cloud Sky Flying-U showing impressive revenue growth rates exceeding 40% in 2024, driven by AI-related business [14][16]. - The software industry reported a total profit of CNY 3,726 billion in the first quarter, reflecting a year-on-year growth of 11.6% [55]. Company Dynamics - Notable company announcements include Keda Guokong's termination of share reduction plans and adjustments in stock repurchase prices by Zhongcheng Technology, indicating stable governance and compliance with regulations [4][56][57]. Financial Performance Overview - The computer sector's financial performance shows a median revenue growth rate of -1.65% for 2024, compared to a median growth rate of 1.51% for all A-shares. The median net profit growth rate for the computer sector is -9.39%, while the overall A-share market shows a median of -2.44% [17][18]. - The report indicates that the computer sector's gross profit margin is projected to be 37.12% in 2024, a decrease of 1.72 percentage points year-on-year, while the net profit margin is expected to be -16.58% [36]. Investment Recommendations - The report suggests continued focus on AI-related sectors, as they are expected to outperform in the challenging macroeconomic environment of 2024, with signs of recovery in profits in early 2025 [5][51].

| 证券代码：300872 | 证券简称：天阳科技 | 公告编号：2025-049 | | --- | --- | --- | | 债券代码：123184 | 债券简称：天阳转债 | | 天阳宏业科技股份有限公司 关于回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次注销的回购股份数量合计 3,000,200 股，占回购注销前公司总股本 （未扣除公司回购专用证券账户中的股份，下同）的 0.65%；本次注销完成 后，公司总股本由 462,895,832 股减少至 459,895,632 股。 2、经中国证券登记结算有限责任公司深圳分公司确认，公司本次回购 股份注销事宜已于 2025 年 4 月 29 日办理完成。 天阳宏业科技股份有限公司（以下简称"公司"）于 2024 年 12 月 10 日、 2024 年 12 月 27 日召开了第三届董事会第二十五次会议以及 2024 年第五次临 时股东大会，审议通过了《关于第二期回购公司股份方案的议案》，同意公司使 用自有资金及/或自筹资金以集中竞价交易方式回购部分公司 ...

| 证券代码：300872 | 证券简称：天阳科技 | 公告编号：2025-050 | | --- | --- | --- | | 债券代码：123184 | 债券简称：天阳转债 | | 天阳宏业科技股份有限公司 关于回购股份注销完成调整可转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 一、关于可转换公司债券转股价格调整的相关规定 （一）可转债基本情况 经中国证券监督管理委员会《关于同意天阳宏业科技股份有限公司向不特定对 象发行可转换公司债券注册的批复》（证监许可〔2023〕47号文）同意注册，天阳宏 业科技股份有限公司（以下简称"公司"）于2023年3月23日向不特定对象发行了975.00 万张可转换公司债券，每张面值100元，发行总额97,500.00万元。经深圳证券交易所 同意，公司可转换公司债券于2023年4月18日起在深圳证券交易所挂牌交易，债券简 称"天阳转债"，债券代码"123184"。 派送现金股利：P1=P0－D； 上述三项同时进行：P1＝（P0－D+A×k）/（1+n+k）。 其中：P0 为调整前转股价，n ...

天阳宏业科技股份有限公司 2025 年第一季度报告 证券代码：300872 证券简称：天阳科技 公告编号：2025-048 债券代码：123184 债券简称：天阳转债 天阳宏业科技股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经过审计 □是 否 1 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 486,808,683.19 | 487,726,342.03 | -0.19% | | 归属于上市公司股东的净利 | 25,596 ...

天阳科技（300872）公告，2025年第一季度营业收入4.87亿元，同比下降0.19%。净利润2559.64万元， 同比下降71.88%。 ...

Investment Rating - The report does not explicitly state an investment rating for the industry, but it suggests a long-term focus on domestic innovative drugs in the oncology field and AI medical investment opportunities [3][4]. Core Insights - The pharmaceutical and biotechnology sector saw a weekly increase of 1.16%, outperforming the Wind All A index (1.15%) and the CSI 300 index (0.38%) [3][8]. - The upcoming ASCO conference is highlighted as a significant event for domestic innovative drug companies, with over 70 oral presentations and more than 10 major studies expected [3][4]. - The Ministry of Industry and Information Technology and six other departments issued a plan for the digital transformation of the pharmaceutical industry, aiming for significant advancements by 2027 and full coverage by 2030 [3][4]. Market Weekly Review - The pharmaceutical and biotechnology sector increased by 1.16% from April 21 to April 25, outperforming the Wind All A index and the CSI 300 index [3][8]. - Notable performers included medical research outsourcing (6.34%) and raw materials (4.72%), while blood products (-3.26%) and vaccines (-6.38%) continued to decline [3][9]. - Individual stock performances showed significant gains for Yong'an Pharmaceutical (31.4%), Shuyou Shen (28.4%), and Erkang Pharmaceutical (27.7%), while *ST Jiyuan (-43.2%), Nanhua Biological (-35.3%), and Shuangcheng Pharmaceutical (-27.7%) faced substantial losses [3][11]. Industry News and Key Company Announcements - On April 25, Kangfang Bio announced FDA approval for its drug Anike for the treatment of recurrent or metastatic nasopharyngeal carcinoma [12]. - The same day, Kangfang Bio also reported the approval of its PD-1/VEGF bispecific antibody for first-line treatment of specific lung cancer types [13]. - The digital transformation plan for the pharmaceutical industry aims to enhance competitiveness and quality management through AI and data integration by 2030 [3][4].

Core Insights - Tianyang Technology reported a revenue of 1.766 billion yuan and a net profit of 77.5 million yuan for the year 2024, with a net cash flow from operating activities of 123 million yuan [1] Group 1: Business Focus and Performance - The company primarily engages in consulting, fintech, digital finance, and financial IT services, focusing on key banking business areas such as credit cards, credit management, and financial markets [1] - In the credit business segment, Tianyang Technology generated nearly 500 million yuan in revenue and launched over 20 new credit-related projects during the year [1] - All projects initiated in 2023 have successfully gone live and are operating stably [1] Group 2: Technological Advancements - The company upgraded three core product technology systems in the credit card sector, including CreditX digital retail products and OmniAcq full-link payment platform, marking significant progress in fintech infrastructure [1] - A strategic partnership was established with SS&C Algo to develop a proprietary Tianyang version that meets domestic innovation requirements, making the company the exclusive agent and service provider for Algo's full line of software products in mainland China [2] Group 3: Research and Development - In 2024, the company invested 327 million yuan in R&D, representing 18.53% of its total revenue, with nearly 70 million yuan generated from artificial intelligence [2] - Over the past three years, total R&D investment has approached 1 billion yuan, with the proportion of R&D spending relative to total revenue increasing rapidly [2] - A strategic cooperation agreement was signed with Hunan University to establish a financial supercomputing innovation center and a joint laboratory for smart financial innovation [2] Group 4: Future Directions - The company aims to explore the application of next-generation artificial intelligence in the financial sector and enhance its product lines and industry presence [3] - There is a commitment to solidifying IT solutions for banks and improving productization and specialization capabilities to become a technology-driven, product-oriented enterprise [3]